NO151461C - Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivaterInfo
- Publication number
- NO151461C NO151461C NO783642A NO783642A NO151461C NO 151461 C NO151461 C NO 151461C NO 783642 A NO783642 A NO 783642A NO 783642 A NO783642 A NO 783642A NO 151461 C NO151461 C NO 151461C
- Authority
- NO
- Norway
- Prior art keywords
- ingrediates
- imidazolide
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU78407 | 1977-10-28 | ||
CH546578A CH642944A5 (en) | 1978-05-19 | 1978-05-19 | Urea derivatives |
CH936778 | 1978-09-06 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO783642L NO783642L (no) | 1979-05-02 |
NO151461B NO151461B (no) | 1985-01-02 |
NO151461C true NO151461C (no) | 1985-04-17 |
Family
ID=27175218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO783642A NO151461C (no) | 1977-10-28 | 1978-10-27 | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater |
Country Status (26)
Country | Link |
---|---|
US (2) | US4407814A (ja) |
EP (1) | EP0001813B1 (ja) |
JP (1) | JPS5470271A (ja) |
AR (2) | AR219560A1 (ja) |
AT (2) | AT366374B (ja) |
AU (1) | AU522536B2 (ja) |
BR (1) | BR7807097A (ja) |
CA (1) | CA1107744A (ja) |
CU (1) | CU34980A (ja) |
DE (2) | DE2846946A1 (ja) |
DK (1) | DK481678A (ja) |
ES (3) | ES474592A1 (ja) |
FI (1) | FI68618C (ja) |
FR (1) | FR2422643A1 (ja) |
GB (1) | GB2008102B (ja) |
GR (1) | GR70681B (ja) |
IE (1) | IE47962B1 (ja) |
IL (1) | IL55773A (ja) |
IT (1) | IT1099450B (ja) |
MC (1) | MC1220A1 (ja) |
NL (1) | NL7810563A (ja) |
NO (1) | NO151461C (ja) |
NZ (1) | NZ188721A (ja) |
PH (1) | PH13569A (ja) |
PT (1) | PT68705A (ja) |
SE (1) | SE7811194L (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI801184A (fi) * | 1979-04-24 | 1980-10-25 | Hoffmann La Roche | Foerfarande foer framstaellning av imidazolidinderivat |
DE2933917A1 (de) * | 1979-08-22 | 1981-03-26 | Basf Ag, 67063 Ludwigshafen | 5-imino-imidazolidin-2-one und diese enthaltende herbizide. |
DE3134933A1 (de) * | 1981-09-03 | 1983-03-31 | Hoechst Ag, 6230 Frankfurt | "harnstoffderivate, verfahren zu ihrer herstellung und diese enthaltende medikamente sowie deren verwendung" |
EP0091596B1 (de) * | 1982-04-08 | 1991-09-11 | Shell Internationale Researchmaatschappij B.V. | Neue Hydantoine, ihre Herstellung und Verwendung |
US5112983A (en) * | 1987-09-28 | 1992-05-12 | Olin Corporation | Process for producing 1,2,4-triazol-5-one using organic sulfonic acids and polymers thereof as a catalyst |
FR2671348B1 (fr) * | 1991-01-09 | 1993-03-26 | Roussel Uclaf | Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
US5411981A (en) * | 1991-01-09 | 1995-05-02 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
USRE35956E (en) * | 1991-01-09 | 1998-11-10 | Roussel Uclaf | Phenylimidazolidines having antiandrogenic activity |
FR2693461B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
FR2694290B1 (fr) * | 1992-07-08 | 1994-09-02 | Roussel Uclaf | Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
FR2724169B1 (fr) * | 1994-09-06 | 1997-01-03 | Roussel Uclaf | Nouvelles phenylimidazolidines eventuellement substituees, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
TW521073B (en) * | 1994-01-05 | 2003-02-21 | Hoechst Marion Roussel Inc | New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them |
FR2715402B1 (fr) * | 1994-01-05 | 1996-10-04 | Roussel Uclaf | Nouvelles phénylimidazolines éventuellement substituées, leur procédé et des intermédiaires de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant. |
FR2741346B1 (fr) * | 1995-11-16 | 1997-12-19 | Roussel Uclaf | Nouveau procede de preparation de derives phenylimidazolidine |
FR2741342B1 (fr) * | 1995-11-22 | 1998-02-06 | Roussel Uclaf | Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques |
US6960474B2 (en) * | 2000-06-28 | 2005-11-01 | Bristol-Myers Squibb Company | Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator |
US6953679B2 (en) | 2000-09-19 | 2005-10-11 | Bristol-Myers Squibb Company | Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof |
EP1854798A3 (en) | 2000-09-19 | 2007-11-28 | Bristol-Myers Squibb Company | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US20040087548A1 (en) | 2001-02-27 | 2004-05-06 | Salvati Mark E. | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
AU2004305075A1 (en) * | 2003-12-19 | 2005-07-07 | The Regents Of The University Of California | Methods and materials for assessing prostate cancer therapies |
NZ550102A (en) * | 2004-02-24 | 2010-10-29 | Univ California | Methods and materials for assessing prostate cancer therapies and compounds (thiohydantoine derivatives) |
US7709517B2 (en) | 2005-05-13 | 2010-05-04 | The Regents Of The University Of California | Diarylhydantoin compounds |
PL2656841T3 (pl) | 2006-03-27 | 2017-01-31 | The Regents Of The University Of California | Modulator receptora androgenowego do leczenia raka gruczołu krokowego i chorób związanych z receptorem androgenowym |
EP2439196A1 (en) | 2006-03-29 | 2012-04-11 | The Regents of The University of California | Diarylthiohydantoin compounds for use in a method for the treatment of a hyperproliferative disorder |
EP2620432A3 (en) | 2007-10-26 | 2013-12-18 | The Regents Of the University of California | Diarylhydantoin compounds |
SG10201907588XA (en) | 2010-02-16 | 2019-09-27 | Aragon Pharmaceuticals Inc | Androgen Receptor Modulators And Uses Thereof |
ES2836424T3 (es) | 2012-09-26 | 2021-06-25 | Aragon Pharmaceuticals Inc | Antiandrógenos para tratar el cáncer de próstata no metastásico y resistente a la castración |
JOP20200097A1 (ar) | 2013-01-15 | 2017-06-16 | Aragon Pharmaceuticals Inc | معدل مستقبل أندروجين واستخداماته |
TWI726969B (zh) | 2016-01-11 | 2021-05-11 | 比利時商健生藥品公司 | 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物 |
KR20200070334A (ko) | 2017-10-16 | 2020-06-17 | 아라곤 파마슈티컬스, 인코포레이티드 | 비-전이성 거세-저항성 전립선암의 치료를 위한 항-안드로겐 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE629779A (ja) * | ||||
US3134663A (en) * | 1957-07-23 | 1964-05-26 | Geigy Chem Corp | Herbicidal composition and method employing hydantoins |
FR1405725A (fr) * | 1963-08-23 | 1965-07-09 | Shell Int Research | Procédé de préparation de la 5, 5-diméthyl-4-iminohydantoine |
NL6904420A (ja) * | 1968-03-28 | 1969-09-30 | ||
US3690863A (en) * | 1968-04-19 | 1972-09-12 | Du Pont | Esters of 3-(carboxyamino)-and 3-(thiocarboxyamino)-2-substituted crotonamides andtheir use as herbicides |
DK123717B (da) * | 1968-11-25 | 1972-07-24 | Sumitomo Chemical Co | 3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning. |
JPS4916937B1 (ja) * | 1970-01-21 | 1974-04-25 | ||
US3676456A (en) * | 1970-02-27 | 1972-07-11 | Ciba Geigy Corp | Derivatives of 3-aryl-5-alkylhydantoins |
JPS5136332B1 (ja) * | 1970-12-09 | 1976-10-07 | ||
US4044021A (en) * | 1971-10-21 | 1977-08-23 | American Cyanamid Company | Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism |
IL45459A (en) * | 1973-09-03 | 1978-01-31 | Ciba Geigy Ag | 1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides |
FR2329276A1 (fr) * | 1975-10-29 | 1977-05-27 | Roussel Uclaf | Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant |
JPS5315373A (en) * | 1976-07-29 | 1978-02-13 | Mitsubishi Chem Ind Ltd | Hydantoin derivatives and fungicides containing same for agriculture and horiticulture |
CA1138334A (en) * | 1977-10-28 | 1982-12-28 | Karl Bernauer | Pharmaceutical preparations containing certain urea derivatives |
US4358606A (en) * | 1981-06-19 | 1982-11-09 | Zoecon Corporation | Esters of phenalkyloxycarbonylamino acids |
-
1978
- 1978-10-13 MC MC781334A patent/MC1220A1/xx unknown
- 1978-10-18 FI FI783170A patent/FI68618C/fi not_active IP Right Cessation
- 1978-10-20 IL IL55773A patent/IL55773A/xx unknown
- 1978-10-20 CA CA313,826A patent/CA1107744A/en not_active Expired
- 1978-10-23 AU AU40961/78A patent/AU522536B2/en not_active Expired
- 1978-10-23 NL NL7810563A patent/NL7810563A/xx not_active Application Discontinuation
- 1978-10-24 IT IT29040/78A patent/IT1099450B/it active
- 1978-10-24 NZ NZ188721A patent/NZ188721A/xx unknown
- 1978-10-25 GR GR57503A patent/GR70681B/el unknown
- 1978-10-25 FR FR7830329A patent/FR2422643A1/fr active Granted
- 1978-10-26 PT PT68705A patent/PT68705A/pt unknown
- 1978-10-26 AR AR274243A patent/AR219560A1/es active
- 1978-10-27 ES ES474592A patent/ES474592A1/es not_active Expired
- 1978-10-27 CU CU7834980A patent/CU34980A/es unknown
- 1978-10-27 EP EP78101244A patent/EP0001813B1/de not_active Expired
- 1978-10-27 GB GB7842247A patent/GB2008102B/en not_active Expired
- 1978-10-27 NO NO783642A patent/NO151461C/no unknown
- 1978-10-27 DE DE19782846946 patent/DE2846946A1/de not_active Withdrawn
- 1978-10-27 AT AT0768978A patent/AT366374B/de active
- 1978-10-27 DK DK481678A patent/DK481678A/da not_active Application Discontinuation
- 1978-10-27 JP JP13177278A patent/JPS5470271A/ja active Granted
- 1978-10-27 BR BR7807097A patent/BR7807097A/pt unknown
- 1978-10-27 DE DE7878101244T patent/DE2861289D1/de not_active Expired
- 1978-10-27 SE SE7811194A patent/SE7811194L/xx unknown
- 1978-10-27 IE IE2130/78A patent/IE47962B1/en unknown
- 1978-10-30 PH PH21743A patent/PH13569A/en unknown
-
1979
- 1979-04-30 ES ES480114A patent/ES480114A1/es not_active Expired
- 1979-04-30 ES ES480109A patent/ES480109A1/es not_active Expired
- 1979-10-02 AR AR278316A patent/AR220004A1/es active
-
1981
- 1981-01-19 AT AT0018281A patent/AT366671B/de not_active IP Right Cessation
- 1981-12-14 US US06/330,364 patent/US4407814A/en not_active Expired - Fee Related
-
1983
- 1983-05-12 US US06/493,855 patent/US4482739A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO151461C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolidinderivater | |
NO151240C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive nitroimidazoler | |
NO148148C (no) | Fremgangsmaate til fremstilling av terapeutisk aktive 4-hydroksy-2-pyrrolidinonderivater | |
NO149962C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO151321C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater | |
NO151463C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
NO156611C (no) | Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre. | |
DK159967C (da) | Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater | |
NO148957C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive cyklopeptider | |
NO144848C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater | |
NO148777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater | |
NO149313C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO151239C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-fenyliminoimidazolidiner | |
NO149037C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO149737C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azaxanthon-3-carboxylsyrer | |
NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
NO148291C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater | |
NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
NO148488C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater | |
NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
NO780644L (no) | Fremgangsmaate til fremstilling av terapeutisk virksomme 9-hydroksyetoksymetylguanin-derivater | |
NO152556C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracen-biskarbonylhydrazoner | |
NO154088C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner. | |
NO149960C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater |